PERI STANGAS: Open Payments
NPI 1043788284 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 11 companies in 2025. Trend: 2023 $369 · 2024 $516 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Abbott Laboratories | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| PFIZER INC. | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| Seqirus USA Inc | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Insulet Corporation | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: FREESTYLE LIBRE 3, AIRSUPRA, Kerendia, Flucelvax, Jornay PM, BREZTRI, Omnipod, FARXIGA.
Industry payments across IN — which companies pay providers there.
